IMMUNOTECH-B Schedules 21 Aug 2026 Board Meeting to Approve 1H26 Interim Results

Bulletin Express

08/11

Immunotech Biopharm Ltd (IMMUNOTECH-B) has announced that its board of directors will convene on 21 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The meeting’s agenda includes consideration of the consolidated financial statements and related matters ahead of their planned publication.

The board is chaired by Executive Director Tan Zheng and comprises six non-executive directors—Yang Fan, Wang Ruihua, Wang Donghu, Yang Xin, Liu Rui and Cao Ran—alongside four independent non-executive directors: Professor Wang Yingdian, Ng Chi Kit, Peng Sujiu and Zhang Guoguang.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1194732077"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194732077\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194732077?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 21:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194732077","market":"us","top_or_hot":-1,"title":"IMMUNOTECH-B Schedules 21 Aug 2026 Board Meeting to Approve 1H26 Interim Results","media":"Bulletin Express","content":"<p>Immunotech Biopharm Ltd (IMMUNOTECH-B) has announced that its board of directors will convene on 21 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The meeting’s agenda includes consideration of the consolidated financial statements and related matters ahead of their planned publication.</p>\n<p>The board is chaired by Executive Director Tan Zheng and comprises six non-executive directors—Yang Fan, Wang Ruihua, Wang Donghu, Yang Xin, Liu Rui and Cao Ran—alongside four independent non-executive directors: Professor Wang Yingdian, Ng Chi Kit, Peng Sujiu and Zhang Guoguang.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IMMUNOTECH-B Schedules 21 Aug 2026 Board Meeting to Approve 1H26 Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIMMUNOTECH-B Schedules 21 Aug 2026 Board Meeting to Approve 1H26 Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-11 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Immunotech Biopharm Ltd (IMMUNOTECH-B) has announced that its board of directors will convene on 21 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The meeting’s agenda includes consideration of the consolidated financial statements and related matters ahead of their planned publication.</p>\n<p>The board is chaired by Executive Director Tan Zheng and comprises six non-executive directors—Yang Fan, Wang Ruihua, Wang Donghu, Yang Xin, Liu Rui and Cao Ran—alongside four independent non-executive directors: Professor Wang Yingdian, Ng Chi Kit, Peng Sujiu and Zhang Guoguang.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06978","symbol_name":"永泰生物-B","start_time":0,"source_url":"","article_id":"1194732077","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194732077","pubTimestamp":1786453556,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Immunotech Biopharm Ltd (IMMUNOTECH-B) has announced that its board of directors will convene on 21 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06978":"永泰生物-B"},"translate_title":"IMMUNOTECH-B 计划于 2026 年 8 月 21 日召开董事会会议，批准 26 年上半年中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06978":1},"content_text":"Immunotech Biopharm Ltd (IMMUNOTECH-B) has announced that its board of directors will convene on 21 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The meeting’s agenda includes consideration of the consolidated financial statements and related matters ahead of their planned publication.\nThe board is chaired by Executive Director Tan Zheng and comprises six non-executive directors—Yang Fan, Wang Ruihua, Wang Donghu, Yang Xin, Liu Rui and Cao Ran—alongside four independent non-executive directors: Professor Wang Yingdian, Ng Chi Kit, Peng Sujiu and Zhang Guoguang.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}